Investing

All Investing Articles

Newest first · Page 30

Leverage Decay Forced MSTU’s 91% Plunge

If you own MSTU, you’re making a specific bet: that MicroStrategy’s Bitcoin holdings will move sharply higher in the near term, and that daily compounding will work in your favor. This ETF delivers 2x…

Austin Smith · 10 months ago

MSTY’s $1.57 Monthly Payments Can’t Offset Share Price Collapse

The YieldMax MSTR Option Income Strategy ETF generates income by selling covered call options on MicroStrategy stock rather than collecting dividends from the underlying company. This structure means MSTY’s monthly distributions depend entirely on…

Michael Williams · 10 months ago

Is Micron Technology the Cheapest AI Stock?

The artificial intelligence (AI) revolution has sparked a new wave of high-performing investments, including Nvidia (NASDAQ:NVDA | NVDA Price Prediction), which has become the face of the industry, while Alphabet (NASDAQ:GOOG)(NASDAQ:GOOGL) has advanced its…

Rich Duprey · 10 months ago

The 4.5% Yield Is Only Half The Story

When bond investors chase yield, they often overlook the engine that drives total returns: price appreciation from interest rate movements. The iShares MBS ETF (NYSEARCA:MBB) demonstrates this dynamic perfectly. While its 4% yield attracts…

Michael Williams · 10 months ago

MCHI Soars 45% as Chinese Equities Break Multi-Year Slump

The iShares MSCI China ETF (NYSEARCA:MCHI) has climbed 45% over the past year, crushing the S&P 500’s 19% gain by more than double. Chinese equities are emerging from a brutal multi-year downturn, and the…

Michael Williams · 10 months ago

3 Beaten-Down Dividend Stocks That Are Must Buys Right Now

Markets have a habit of throwing babies out with the bathwater. Dividend stocks like Noble Corporation (NYSE:NE | NE Price Prediction), Booz Allen Hamilton (NYSE:BAH), and United Parcel Service (NYSE:UPS) present the perfect buy-the-dip…

Omor Ibne Ehsan · 10 months ago

Vanguard Lets Investors Bet on Cheap Big Tech Stocks The Easy Way | MGV

When growth stocks dominate headlines and valuations stretch, finding established companies trading at reasonable prices becomes harder. Vanguard Mega Cap Value Index Fund ETF Shares (NYSEARCA:MGV) offers exposure to the largest U.S. companies trading…

Michael Williams · 10 months ago

Is Apellis Pharmaceuticals’ FDA Win Just the Beginning?

When Apellis Pharmaceuticals (APLS) secured FDA approval for EMPAVELI in C3 glomerulopathy and IC-MPGN last summer, the stock was trading near $28. Today it sits at $19.96, down 31% over the past year. That…

William Temple · 10 months ago